Cerence Inc.
NASDAQ:CRNCSoftware - Application
+$0.25 today
- Market cap
- $315.71M
- Beta
- 2.98
- P/E (TTM)
- -23.5
- EPS (TTM)
- -$0.44
Volume 0.59M
Average 1.01M
CRNC Sales of Investments
Cash received from selling or redeeming investments.
Cerence Inc.NASDAQ: CRNC
Sales of Investments · Q2 FY2026 · quarter ended Mar 2026
Sales of investments growth accelerates
Q2 FY2026 sales of investments of $2.54M rose 153.9% year over year, ahead of the -49.1% change in trailing-twelve-month sales of investments. Sequentially, it rose 186.6% from the prior quarter. Over 3 fiscal years it compounded at -47.1% a year.
Context
- Sales of investments amounted to 2.2% of revenue in FY2025, down 1.2 pp from a year earlier.
- Sales of investments increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +153.9% holds above the trailing-twelve-month pace of -49.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 5.51M USD
- Year-over-year change
- -50.4%
- 4-year CAGR
- -23.8%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 5.51M | -50.4% |
| FY2024 | 2024-09-30 | 11.11M | -63.4% |
| FY2023 | 2023-09-30 | 30.32M | -18.5% |
| FY2022 | 2022-09-30 | 37.2M | +127.5% |
| FY2021 | 2021-09-30 | 16.35M | — |
Sales of Investments vs competitors
How CRNC compares with its peers on the latest reported figures
- CRNC's LTM Mar 2026 sales of investments of $5.44M is the 6th largest of the 11 companies compared; the peer median is $8.07M.
- Its year-over-year change of -49.1% is the 4th highest of 6, against a peer median of -26.3%.
- Sales of investments amounts to 1.8% of revenue for CRNC, versus a peer median of 1.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $196.81M | +413.8% | — | 121.4% | |
CMRCCommerce.com, Inc. | LTM Mar 2026 | $82.7M | -56.1% | -5.5% | 23.8% |
| LTM Mar 2026 | $60.91M | +0.3% | -35.0% | 32.1% | |
| LTM Mar 2026 | $45.15M | -26.3% | — | 18.2% | |
| LTM Mar 2026 | $16.13M | -69.6% | -55.4% | 2.0% | |
| LTM Mar 2026 | $5.44M | -49.1% | -47.1% | 1.8% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Apr 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CRNC) | $8.07M | -26.3% | -35.0% | 1.0% | |
Competitors are the stored peer set for CRNC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Net Income | 45.89M | (310.83M) | (56.25M) | (588.08M) | (18.71M) |
| Depreciation & Amortization | 29.66M | 23.94M | 16.04M | 10.63M | 10.55M |
| Deferred Income Tax | (4.42M) | 97.29M | 7.6M | (4.66M) | 241K |
| Stock-Based Compensation | 60.56M | 28.08M | 40.77M | 23.67M | 27.35M |
| Change in Working Capital | (61.29M) | (65.32M) | (1.74M) | (41.63M) | 36.53M |
| Accounts Receivables | 5.75M | (6.59M) | (16.96M) | 11.76M | (1.4M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 3.41M | 157K | 5.77M | (12.56M) | (3.15M) |
| Other Working Capital | (70.46M) | (58.88M) | 9.45M | (40.83M) | 41.08M |
| Other Non-Cash Items | 3.99M | 224.7M | 1.09M | 617.26M | 5.21M |
| Operating Cash Flow | 74.39M | (2.14M) | 7.5M | 17.2M | 61.17M |
| Capital Expenditures | (12.05M) | (17.45M) | (5.12M) | (5M) | (14.36M) |
| Acquisitions (Net) | (2.56M) | (584K) | 0 | 0 | 0 |
| Purchases of Investments | (44.47M) | (31.76M) | (18.03M) | 0 | 0 |
| Sales of Investments | 16.35M | 37.2M | 30.32M | 11.11M | 5.51M |
| Other Investing Activities | 1.1M | 2.02M | (1.36M) | (1.74M) | (1.71M) |
| Investing Cash Flow | (41.63M) | (10.57M) | 5.82M | 4.38M | (10.55M) |
| Debt Repayment | (6.74M) | (6.67M) | 11.11M | (392K) | (87.5M) |
| Common Stock Issued | 11.52M | 36.06M | 5.63M | 10.9M | 2.88M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (46.29M) | (49M) | (22.07M) | (10.28M) | (2.38M) |
| Financing Cash Flow | (41.51M) | (19.61M) | (5.33M) | 225K | (87M) |
| Effect of Forex Changes | 1.11M | (1.27M) | (1.68M) | (1.47M) | (1.09M) |
| Net Change in Cash | (7.64M) | (33.58M) | 6.31M | 20.33M | (37.47M) |
| Free Cash Flow | 62.34M | (19.58M) | 2.37M | 12.2M | 46.82M |
Cerence Inc.
NASDAQ:CRNC
Intrinsic Alpha fair value
Locked
Current Price
$6.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.